2016\u5e748\u670816\u65e5<\/p>\n
³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ)\u306f\u3001³Ô¹Ï±¬ÁÏ KOL Data<\/a><\/span>\u3092\u7d71\u62ec\u3059\u308b\u30bc\u30cd\u30e9\u30eb\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u3001Kilian Weiss\u304cPharmaVOICE<\/em>\u8a8c<\/a><\/span>\u3067\u4eca\u5e74\u306e\u300c\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u3067\u6700\u3082\u5f71\u97ff\u529b\u306e\u3042\u308b100\u4eba\u300d\u306b\u9078\u51fa\u3055\u308c\u305f\u3068\u767a\u8868\u3057\u307e\u3057\u305f\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c2016\u5e748\u670810\u65e5\u306b\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059)<\/p>\n Kilian\u306f\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u30c7\u30fc\u30bf\u306b\u7cbe\u901a\u3057\u305f\u4e16\u754c\u5c48\u6307\u306e\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u3068\u3057\u3066\u300110\u5e74\u9593\u306b\u308f\u305f\u308a\u3001 \u8907\u96d1\u306a\u30c7\u30fc\u30bf\u3084\u5206\u6790\u304b\u3089\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306b\u3068\u3063\u3066\u306e\u4fa1\u5024\u3092\u751f\u307f\u51fa\u305d\u3046\u3068\u5c3d\u529b\u3057\u3066\u304d\u307e\u3057\u305f\u3002\u305d\u306e\u539f\u70b9\u306f\u3001\u30d5\u30e9\u30f3\u30af\u30d5\u30eb\u30c8\u5927\u5b66\u3067\u30bd\u30fc\u30b7\u30e3\u30eb\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u306e\u7814\u7a76\u3092\u3057\u3066\u3044\u305f\u969b\u306b\u601d\u3044\u63cf\u3044\u305f\u30d3\u30b8\u30e7\u30f3\u3067\u3059\u3002\u4f01\u696d\u304c\u65ad\u7247\u5316\u3055\u308c\u305f\u9867\u5ba2\u30c7\u30fc\u30bf\u3084\u305d\u306e\u5206\u6790\u7d50\u679c\u3092\u6d3b\u7528\u3067\u304d\u308b\u3088\u3046\u30b5\u30dd\u30fc\u30c8\u3057\u305f\u3044\u3068\u3044\u3046\u601d\u3044\u3067\u3057\u305f\u3002\u5f7c\u306f\u3053\u306e10\u5e74\u3067\u3001\u30d7\u30e9\u30a4\u30de\u30ea\u30fc\u30ea\u30b5\u30fc\u30c1\u3084\u30af\u30e9\u30a6\u30c9\u30bd\u30fc\u30b7\u30f3\u30b0\u3001\u533b\u7642\u30c8\u30e9\u30f3\u30b6\u30af\u30b7\u30e7\u30f3\u30c7\u30fc\u30bf\u3092\u7d44\u307f\u5408\u308f\u305b\u3066\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u9867\u5ba2\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u3092\u69cb\u7bc9\u3057\u307e\u3057\u305f\u3002\u305d\u306e\u5148\u9032\u7684\u306a\u30a2\u30d7\u30ed\u30fc\u30c1\u306f\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306b\u65b0\u98a8\u3092\u5439\u304d\u8fbc\u307f\u3001\u7d71\u5408\u578b\u30e2\u30c7\u30eb\u3092\u5b9f\u73fe\u3059\u308b\u3053\u3068\u3067\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u306e\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u5411\u4e0a\u306b\u5f79\u7acb\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ\u306e\u793e\u9577\u517c\u5171\u540c\u5275\u696d\u8005Matt Wallach\u306f\u6b21\u306e\u3088\u3046\u306b\u8a55\u3057\u3066\u3044\u307e\u3059\u3002\u300cKilian\u306f\u30d8\u30eb\u30b9\u30b1\u30a2\u696d\u754c\u5168\u822c\u306e\u8907\u96d1\u306a\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u30c7\u30fc\u30bf\u3092\u53ce\u96c6\u30fb\u5206\u6790\u3059\u308b\u305f\u3081\u306b\u3001\u753b\u671f\u7684\u306a\u65b9\u6cd5\u3092\u8003\u6848\u3057\u3066\u304d\u305f\u7d20\u6674\u3089\u3057\u3044\u4eba\u6750\u3067\u3059\u3002\u5f7c\u306e\u53d6\u308a\u7d44\u307f\u306f\u540c\u696d\u754c\u306b\u8ca2\u732e\u3057\u3001\u3053\u308c\u304b\u3089\u3082\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u304c\u30c7\u30fc\u30bf\u3092\u3082\u3068\u306b\u60a3\u8005\u69d8\u306b\u9069\u3057\u305f\u533b\u85ac\u54c1\u3084\u6cbb\u7642\u3092\u63d0\u4f9b\u3059\u308b\u4e0a\u3067\u5f79\u7acb\u3064\u3067\u3057\u3087\u3046\u3002\u300d<\/p>\n ³Ô¹Ï±¬ÁÏ\u306fKilian\u306e\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u306e\u3082\u3068\u3067\u30012015\u5e74\u306bKOL Data\u3092\u767a\u8868\u3002\u305d\u308c\u304b\u30891\u5e74\u3067\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306e\u30c8\u30c3\u30d720\u4f01\u696d\u306e\u3046\u30615\u793e\u304c\u5f53\u793e\u306e\u9867\u5ba2\u306b\u306a\u308a\u307e\u3057\u305f\u3002\u3053\u306e\u30b5\u30d6\u30b9\u30af\u30ea\u30d7\u30b7\u30e7\u30f3\u578b\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306f\u591a\u5f69\u306a\u30c7\u30fc\u30bf\u30bd\u30fc\u30b9\u3092\u7d44\u307f\u5408\u308f\u305b\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306b\u3068\u3063\u3066\u91cd\u8981\u306a\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\uff08\u30bd\u30fc\u30c8\u30ea\u30fc\u30c0\u30fc\u3001\u652f\u6255\u8005\u3001\u898f\u5236\u5f53\u5c40\uff09\u3092\u7db2\u7f85\u3059\u308b\u3053\u3068\u3067\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306aKOL\u30c7\u30fc\u30bf\u306b\u95a2\u3059\u308b\u7dcf\u5408\u7684\u306a\u77e5\u898b\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u73fe\u5834\u306e\u55b6\u696d\u62c5\u5f53\u8005\u306f\u9762\u8ac7\u306e\u6e96\u5099\u306b\u304b\u3051\u308b\u6642\u9593\u3092\u6570\u6642\u9593\u304b\u3089\u6570\u5206\u306b\u77ed\u7e2e\u3057\u3001\u52b9\u7387\u3092\u9ad8\u3081\u3001\u4f01\u696d\u5168\u4f53\u306e\u4fa1\u5024\u3092\u5411\u4e0a\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002<\/p>\n \u300c\u305d\u306e\u5834\u3057\u306e\u304e\u306eKOL\u30c7\u30fc\u30bf\u53ce\u96c6\u304b\u3089\u3001\u5e38\u306b\u66f4\u65b0\u3055\u308c\u305f\u9ad8\u5ea6\u306a\u60c5\u5831\u3078\u3068\u79fb\u884c\u3059\u308c\u3070\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306f\u606f\u306e\u9577\u3044\u4eba\u9593\u95a2\u4fc2\u3092\u69cb\u7bc9\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u300d\u3068Kilian Weiss\u306f\u8a00\u3044\u307e\u3059\u3002\u300cPharmaVOICE\u8a8c\u306b\u8a8d\u3081\u3066\u3044\u305f\u3060\u304d\u3001\u672c\u5f53\u306b\u5149\u6804\u3067\u3059\u3002\u4eca\u5f8c\u3082\u3001\u696d\u754c\u968f\u4e00\u306e\u54c1\u8cea\u3068\u30b9\u30b1\u30fc\u30eb\u3067\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u30c7\u30fc\u30bf\u306e\u7dcf\u5408\u7684\u306a\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u3092\u63d0\u4f9b\u3059\u308b\u3068\u3044\u3046\u4f7f\u547d\u3092\u679c\u305f\u3057\u3066\u3044\u304d\u305f\u3044\u3068\u601d\u3044\u307e\u3059\u3002\u300d<\/p>\n PharmaVOICE 100\u306b\u306f\u3001\u3055\u307e\u3056\u307e\u306a\u696d\u7a2e\u3084\u5206\u91ce\u3067\u540c\u696d\u8005\u3084\u4f01\u696d\u5404\u793e\u3001\u305d\u3057\u3066\u30d8\u30eb\u30b9\u30b1\u30a2\u30b3\u30df\u30e5\u30cb\u30c6\u30a3\u5168\u4f53\u306b\u591a\u5927\u306a\u5f71\u97ff\u529b\u3092\u6301\u3064\u7b2c\u4e00\u4eba\u8005\u304c\u540d\u3092\u9023\u306d\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u30a8\u30ea\u30fc\u30c8\u96c6\u56e3\u306f\u3001\u60c5\u71b1\u3084\u30a2\u30a4\u30c7\u30a2\u3067\u696d\u754c\u3092\u30ea\u30fc\u30c9\u3057\u3001\u30e6\u30cb\u30fc\u30af\u306a\u30a2\u30d7\u30ed\u30fc\u30c1\u3067\u7a4d\u6975\u7684\u306b\u8ca2\u732e\u3057\u3001\u696d\u754c\u304c\u76f4\u9762\u3059\u308b\u5927\u304d\u306a\u8ab2\u984c\u306b\u53d6\u308a\u7d44\u307f\u3001\u9769\u65b0\u7684\u306a\u6226\u7565\u3084\u88fd\u54c1\u3001\u30b5\u30fc\u30d3\u30b9\u3092\u751f\u307f\u51fa\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n <\/p>\n \u3010<\/strong>³Ô¹Ï±¬ÁÏ Systems<\/strong>\u793e\u306b\u3064\u3044\u3066\u3011<\/strong> <\/p>\n \u3010Forward-looking Statements\u3011<\/strong> 2016\u5e748\u670816\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e ³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751…<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322],"tags":[],"class_list":["post-39062","post","type-post","status-publish","format-standard","hentry","category-press-release","blog-product-data","blog-product-networkopendata"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/39062"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=39062"}],"version-history":[{"count":3,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/39062\/revisions"}],"predecessor-version":[{"id":39066,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/39062\/revisions\/39066"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=39062"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=39062"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=39062"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067400\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u3092\u64c1\u3057\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/span>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations\u201d in the company\u2019s filing on Form 10-Q for the period ended July 31, 2015. This is available on the company\u2019s website at http:\/\/www.veeva.com<\/span> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/span>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"